Top Markets
Coin of the day
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
주식 순위 #27877
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
주가
$0.04861197
시가총액
$30.02M
변동 (1일)
0.00%
변동 (1년)
-91.39%
국가
CN
거래 Immunotech Biopharm Ltd (6978)

카테고리

Immunotech Biopharm Ltd (6978)의 주식 분할 이력
Immunotech Biopharm Ltd 주식 (심볼: 6978)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 20, 2026에 발생했습니다.
Aug 20, 2026 이전에 매수한 6978 주식 1주는 현재 0주의 6978 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH